Suzanne M. Sensabaugh is President of HartmannWillner LLC, where she provides professional advice to clients. She has over 20 years of experience in regulatory affairs, drug development, and FDA compliance with a focus on biologics, biosimilars, and biologic/device combination products. Her experience was gained in the FDA, the pharmaceutical industry, and consulting environments. She had 10 years of experience at the FDA as a researcher, product reviewer, and inspector for biologics. Her industry career began at Genzyme Corporation. Suzanne has held numerous senior management and executive positions at Teva Pharmaceutical Industries, MDS Pharma Services, and Panacea Pharmaceuticals. She received her MBA from Duke University, MS from Johns Hopkins University, and BS from the University of Maryland. Suzanne is Adjunct Faculty at Johns Hopkins University.

Suzanne has been developing and gaining approval for Biosimilars for over 10 years.